Mental Health
Tailored Antipsychotics Lower Cannabis Psychosis Relapse, Swedish Study Shows
Tailored Antipsychotics Lower Cannabis Psychosis Relapse, Swedish Study Shows Introduction: Navigating the Complexities of Cannabis-Induced Psychosis Recent research from Sweden highlights that tailored antipsychotic treatments may significantly reduce the risk of relapse in patients experiencing cannabis-induced psychosis (CIP). With an average patient age of 26.6 years, the study analyzed data Read more…